Addition of 16 new agents and several new supplemental indications that have all been approved by the FDA within the past year
Updated new indications for previously approved agents
Indications, drug doses and schedules, toxicities, and special considerations for each agent expanded and revised
A specific chapter focused on antiemetic treatment regimens for both acute and delayed nausea/vomiting
Diagrams of drug structures and pathways for many of the agents
A comprehensive discussion of clinical pharmacology, special considerations, indications, and dosages
Covers toxicity and drug–drug interactions
A section on chemotherapy regimens for all major cancers
Provides an overview of the basic principles of cancer drug therapy











